Stryker Corporation has a robust track record of double-digit earnings growth and high single-digit organic revenue growth.

Stryker's 8% CAGR revenue growth over the past 12 years was driven by organic growth and acquisitions. Learn more about SYK ...

CX Institutional lifted its position in shares of Stryker Co. (NYSE:SYK – Free Report) by 3.9% in the 3rd quarter, according ...

Stryker (NYSE: SYK) announced today that it has completed the acquisition of Vertos Medical Inc., a leader in interventional pain management solutions for chronic lower back pain caused by lumbar ...

In the assessment of 12-month price targets, analysts unveil insights for Stryker, presenting an average target of $377.62, a ...

“When you go inside the body, with a surgeon doing, let’s say, a gallbladder procedure, fluorescence lights up the anatomy.

Stryker (NYSE: SYK) is a medical device company that has risen to become the third-largest U.S. firm in the healthcare ...

BTIG raised the firm’s price target on Stryker to $383 from $374 and keeps a Buy rating on the shares as part of a broader ...

Medical technologies giant Stryker announced on Tuesday, October 1st, that it completed the acquisition of Vertos Medical for ...

Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointments of Timothy J. Scannell and Wendy E. Lane to the Company's Board of Directors (the "Board"), ...

Doubts have emerged over the Indian Army’s plan to procure the Stryker armoured combat vehicle as relations between India and Canada have nosedived. Manufactured by General Dynamics Land ...

Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot ...